Authors:
Jin, FQ
Wang, DJ
Confalone, PN
Pierce, ME
Wang, Z
Xu, GY
Choudhury, A
Nguyen, D
Citation: Fq. Jin et al., (2R,3S,5S)-2-acetoxy-3-fluoro-5-(p-toluoyloxymethyl)tetrahydrofuran: a keyintermediate for the practical synthesis of 9-(2,3-dideoxy-2-fluoro-beta-D-threo-pentofuranosyl)adenine (FddA), TETRAHEDR L, 42(29), 2001, pp. 4787-4789
Citation: A. Choudhury et al., Oxidative removal of p-methoxybenzyl-amino protecting group in the presence of a proximal hydroxy function: A solution to a process problem in SUSTIVA (R) (efavirenz) synthesis, SYN COMMUN, 31(23), 2001, pp. 3707-3714
Authors:
Kauffman, GS
Harris, GD
Dorow, RL
Stone, BRP
Parsons, RL
Pesti, JA
Magnus, NA
Fortunak, JM
Confalone, PN
Nugent, WA
Citation: Gs. Kauffman et al., An efficient chiral moderator prepared from inexpensive (+)3-carene: Synthesis of the HIV-1 non-nucleoside reverse transcriptase inhibitor DPC 963, ORG LETT, 2(20), 2000, pp. 3119-3121
Authors:
Mousa, SA
Forsythe, M
Bozarth, J
Jin, FQ
Confalone, PN
Citation: Sa. Mousa et al., Human platelet alpha IIb beta 3 integrin binding affinity end specificity of SJ874: antiplatelet efficacy versus aspirin, CORON ART D, 11(7), 2000, pp. 563-570
Authors:
Wang, Z
Xu, GY
Wang, DJ
Pierce, ME
Confalone, PN
Citation: Z. Wang et al., Chemoselective allylic addition of allyltrichlorosilane to alpha-oxocarboxylic acids: synthesis of tertiary alpha-hydroxy carboxylic acids, TETRAHEDR L, 41(23), 2000, pp. 4523-4526
Citation: Na. Magnus et al., A new asymmetric 1,4-addition method: application to the synthesis of the HIV non-nucleoside reverse transcriptase inhibitor DPC 961, TETRAHEDR L, 41(17), 2000, pp. 3015-3019
Citation: Pn. Confalone, Principles of process research and chemical development in the pharmaceutical industry (vol 42, pg 3008, 1999), J MED CHEM, 43(26), 2000, pp. 5057-5057
Authors:
Richards, LE
Pieniaszek, HJ
Shatzmiller, S
Page, GO
Blom, KF
Read, JM
Davidson, AF
Confalone, PN
Citation: Le. Richards et al., Human moricizine metabolism. I. Isolation and identification of metabolites in human urine (vol 27, pg 217, 1997), XENOBIOTICA, 29(9), 1999, pp. 969-969
Citation: Pn. Confalone et Re. Waltermire, The process research and development of DuPont Merck's cyclic urea diols, a new class of HIV protease inhibitors, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, 1999, pp. 201-219